GTBIF (Green Thumb Industries) Debt-to-Asset : 0.21 (As of Sep. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Green Thumb Industries Debt-to-Asset?

Green Thumb Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $23 Mil. Green Thumb Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $507 Mil. Green Thumb Industries's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was $2,515 Mil. Green Thumb Industries's debt to asset for the quarter that ended in Sep. 2024 was 0.21.

Green Thumb Industries Debt-to-Asset Historical Data

The historical data trend for Green Thumb Industries's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Thumb Industries Debt-to-Asset Chart

Green Thumb Industries Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Feb18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.13

0.18

0.22

0.23

Green Thumb Industries Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.22	0.23	0.23	0.23	0.21

Competitive Comparison of Green Thumb Industries's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Green Thumb Industries's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Green Thumb Industries's Debt-to-Asset falls into.

Green Thumb Industries Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Green Thumb Industries's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(15.293	+	554.991)	/	2490.057
	=	0.23

Green Thumb Industries's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(22.726	+	506.972)	/	2514.872
	=	0.21

Green Thumb Industries (OTCPK:GTBIF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Green Thumb Industries Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Green Thumb Industries's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Green Thumb Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Thumb Industries Inc (OTCPK:GTBIF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

R9U2:Germany R9U2:Germany GTII:Canada

Address

325 West Huron Street, Suite 700, Chicago, IL, USA, 60654

Website

https://www.gtigrows.com

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 97 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RYTHM.

Executives

Richard Reisin	director	325 W. HURON STREET, SUITE 700, CHICAGO IL 60654
Hannah Scofield Buchan	director	660 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10065
Ethan Nadelmann	director	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Dawn Wilson Barnes	director	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Bret Kravitz	officer: GENERAL COUNSEL AND SECRETARY	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Jeffrey H Goldman	director	325 W HURON STREET, SUITE 700, CHICAGO IL 60654
Richard A Drexler	director	200 S MICHIGAN AVE, SUITE 1300, CHICAGO IL 60604
Dorri Mcwhorter	director	6431 OAKTON STREET, C/O LIFEWAY FOODS, INC., MORTON GROVE IL 60053
Swati Mylavarapu	director	325 W. HURON ST., SUITE 700, CHICAGO IL 60654
Mathew Faulkner	officer: Chief Accounting Officer	325 W. HURON, SUITE 412, CHICAGO IL 60654
Beth Elaine Burk	officer: General Counsel	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Benjamin Kovler	director, 10 percent owner, officer: Chairman & CEO	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Armen Yemenidjian	officer: President	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Jennifer Dooley	other: Chief Strategy Officer	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Westley Moore	director	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654